Cumberland Pharmaceuticals Inc. (CPIX) Financial Statements (2024 and earlier)

Company Profile

Business Address 2525 WEST END AVENUE
NASHVILLE,, TN 37203
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments19,75827,04124,75428,21336,23050,085
Cash and cash equivalents19,75827,04124,75428,21327,93945,413
Short-term investments     8,2914,672
Receivables13,1646,87712,3789,7817,8448,395
Inventory, net of allowances, customer advances and progress billings9,8648,43010,6389,41212,0786,738
Inventory9,8648,43010,6389,41212,0786,738
Other undisclosed current assets3,0853,3402,2002,7572,9643,467
Total current assets:45,87045,68849,97050,16359,11668,685
Noncurrent Assets
Inventory, Noncurrent7,5279,049    
Operating lease, right-of-use asset5,2181,0242,028 
Property, plant and equipment284443574748771529
Intangible assets, net (including goodwill)31,50524,83629,00031,80234,43921,445
Goodwill914882882882784 
Intangible assets, net (excluding goodwill)30,59123,95428,11830,92033,65521,445
Deferred costs   2,9003,1002,300 
Other noncurrent assets2,5213,4203,2343,2992,5312,487
Deferred tax assets, net228787
Other undisclosed noncurrent assets   8,75715,41613,449 
Total noncurrent assets:47,05538,77246,49454,38653,57824,547
TOTAL ASSETS:92,92584,46096,463104,549112,69493,232
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28,40718,30924,65123,23027,80417,695
Accounts payable10,8199,64113,39611,91211,0938,980
Accrued liabilities 17,5888,66811,25411,31716,7118,715
Other liabilities      
Other undisclosed current liabilities1739701,017920  
Total current liabilities:28,58019,27925,66724,15027,80417,695
Noncurrent Liabilities
Long-term debt and lease obligation16,20015,09016,06018,50020,0009,800
Long-term debt, excluding current maturities16,20015,00015,00018,50020,0009,800
Liabilities, other than long-term debt12,1717,4897,8638,7379,3191,816
Other liabilities7,5857,4897,8638,7379,3191,816
Operating lease, liability4,586901,060 
Other undisclosed noncurrent liabilities    2,076  
Total noncurrent liabilities:28,37122,57923,92229,31429,31911,616
Total liabilities:56,95141,85849,59053,46457,12329,311
Equity
Equity, attributable to parent, including:36,26642,81446,99151,12355,84564,120
Retained earnings (accumulated deficit)(11,209)(5,639)(2,131)1,2084,74611,709
Other undisclosed equity, attributable to parent47,47548,45349,12249,91451,09952,411
Equity, attributable to noncontrolling interest(292)(212)(117)(38)(274)(199)
Total equity:35,97442,60246,87351,08555,57163,922
TOTAL LIABILITIES AND EQUITY:92,92584,46096,463104,549112,69493,232

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues42,01135,98537,44147,53440,7421,600
Revenue, net41,150
Cost of revenue
(Cost of Goods and Services Sold)
(9,119)(8,811)(8,653)(8,752)(7,378)(7,371)
Gross profit:32,89227,17428,78838,78233,364(5,771)
Operating expenses(38,597)(34,851)(35,170)(42,405)(40,754)(37,861)
Other undisclosed operating income      39,550
Operating loss:(5,705)(7,677)(6,382)(3,623)(7,391)(4,081)
Nonoperating income
(Investment Income, Nonoperating)
7102675243564299
Interest and debt expense(586)(98)(264)(246)(196)(93)
Loss from continuing operations before equity method investments, income taxes:(5,581)(7,749)(6,570)(3,626)(7,022)(3,875)
Other undisclosed income from continuing operations before income taxes 2,187    
Loss from continuing operations before income taxes:(5,581)(5,562)(6,570)(3,626)(7,022)(3,875)
Income tax expense (benefit)(69)(35)(56)79(17)(4,175)
Loss from continuing operations:(5,650)(5,597)(6,626)(3,547)(7,039)(8,050)
Loss before gain (loss) on sale of properties:(3,603)(3,419)(3,547)(7,039)(8,050)
Income from discontinued operations  1,9943,207   
Net loss:(5,650)(3,603)(3,419)(3,547)(7,039)(8,050)
Net income attributable to noncontrolling interest80957997671
Net loss available to common stockholders, diluted:(5,570)(3,508)(3,339)(3,538)(6,963)(7,979)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(5,650)(3,603)(3,419)(3,547)(7,039)(8,050)
Other undisclosed comprehensive income    97671
Comprehensive loss:(5,650)(3,603)(3,419)(3,538)(6,963)(7,979)
Comprehensive income, net of tax, attributable to noncontrolling interest80957918151142
Other undisclosed comprehensive loss, net of tax, attributable to parent    (26)(227)(214)
Comprehensive loss, net of tax, attributable to parent:(5,570)(3,508)(3,339)(3,547)(7,039)(8,050)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: